1634-33-9

Upstream product

• 1634-34-0 2',6'-dihydroxy-4'-methylacetophenone 

Downstream Products

• 1380699-26-2 1-(2,6-dihydroxy-4-methylphenyl)ethanone O-acetyloxime 
• 1380696-12-7 (5R)-3-{4-[(3,6-dimethyl-1,2-benzisoxazol-4-yl)oxy]phenyl}-5-methyl-2,4-imidazolidinedione 
• 1380697-25-5 3,6-dimethyl-4-[(4-nitrophenyl)oxy]-1,2-benzisoxazole 
• 1380697-26-6 {4-[(3,6-dimethyl-1,2-benzisoxazol-4-yl)oxy]phenyl}amine 
• 1380697-27-7 1,1-dimethylethyl [(1R)-2-({4-[(3,6-dimethyl-1,2-benzisoxazol-4-yl)oxy]phenyl}amino)-1-methyl-2-oxoethyl]carbamate 
• 1380697-28-8 N₁-{4-[(3,6-dimethyl-1,2-benzisoxazol-4-yl)oxy]phenyl}-D-alaninamide 

Relevant academic research and scientific papers

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.